Pacific Northwest Diabetes Institute

In FY 2010, EDA provided a $2 million grant to the Pacific Northwest Diabetes Institute to fund the acquisition of new technology and upgrades of scientific equipment. The grant also funded instrumentation to support new hi-tech companies in their research facility and medical technology incubator. The project was intended to address severe job loss in the biotech and life science sectors in metropolitan Puget Sound, Washington.

After six years, the Pacific Northwest Diabetes Institute has indicated that the project has resulted in $500,000 in private investment, created 184 jobs, and retained 110 jobs for a total of 294 jobs. Several tenant companies were established and the Institute has also licensed product inventions to large companies including Eli Lilly and Merck.